Search Results - Simon P

  • Showing 1 - 15 results of 15
Refine Results
  1. 1
  2. 2

    Anti Doping by Neuberger E, Simon P

    Published 2014-10-01 Get full text
    Article
  3. 3
  4. 4

    Title not available by Wackerhage H, Everett R, Krüger K, Murgia M, 5, Simon P, Gehlert S, Neuberger E, Baumert P, Schönfelder M

    Published 2020-05-01

    No health emergency in living memory has ever had greater repercussions for our health, economy and the way we live than the COVID-19 pandemic caused by SARS-CoV-2, commonly referred to as the coronavirus. COVID-19 has many links to sport and exercise: sports events such as the champions league quar...

    Full description

    Get full text
    Article
  5. 5

    Tackle characteristics associated with concussion in elite men’s rugby union: unpicking the differences between tacklers and ball-carriers by Keith A Stokes, Simon P T Kemp, Ben Jones, Sean Williams, Duncan Locke, Simon Roberts, Stephen W West, Steffan Griffin, Matt Cross

    Published 2025-08-01

    Objective To identify characteristics of tackling, of being tackled and interactions between tackle characteristics that are associated with concussion.Methods A case-control study in male professional rugby union players in England over five seasons (2016/2017 to 2020/2021) analysed characteristics...

    Full description

    Get full text
    Article
  6. 6

    External validity of randomized controlled trials in older adults, a systematic review. by Floor J van Deudekom, Iris Postmus, Danielle J van der Ham, Alexander B Pothof, Karen Broekhuizen, Gerard J Blauw, Simon P Mooijaart

    Published 2017-01-01

    <h4>Background</h4>To critically assess the external validity of randomized controlled trials (RCTs) it is important to know what older adults have been enrolled in the trials. The aim of this systematic review is to study what proportion of trials specifically designed for older patient...

    Full description

    Get full text
    Article
  7. 7

    Spatiotemporal Distribution and Risk Factors of African Swine Fever Outbreak Cases in Uganda for the Period 2010–2023 by Eddie M. Wampande, Robert Opio, Simon P. Angeki, Corrie Brown, Bonto Faburay, Rose O. Ademun, Kenneth Ssekatawa, David D. South, Charles Waiswa, Peter Waiswa

    Published 2025-07-01

    This paper describes the spatiotemporal distribution and risk factors of African Swine Fever (ASF) in Uganda for the period of 2010 through 2023. The study utilized a comprehensive dataset from monthly reports (2010–2023) from District Veterinary Officers (DVOs), the Ministry of Agriculture, Animal...

    Full description

    Get full text
    Article
  8. 8

    Azithromycin and oesophageal motility in chronic respiratory disease: a feasibility study by Dominic L. Sykes, Kayleigh Brindle, Rohan Menon, Simon P. Hart, Jennifer Nielsen, Warren Jackson, John Gallagher, Elisabeth Kirton, Mengru Zhang, Alyn H. Morice, Michael G. Crooks

    Published 2025-07-01

    Background: The role of the gut-lung axis in respiratory disease is increasingly recognised. Much emphasis has been placed on gastro-oesophageal reflux disease; however, oesophageal dysmotility may also play a significant role. Azithromycin, a known prokinetic, has been shown to be of major benefit...

    Full description

    Get full text
    Article
  9. 9
  10. 10

    Clinical applications of next‐generation sequencing‐based ctDNA analyses in breast cancer: defining treatment targets and dynamic changes during disease progression by Eva Valentina Klocker, Samantha Hasenleithner, Rupert Bartsch, Simon P. Gampenrieder, Daniel Egle, Christian F. Singer, Gabriel Rinnerthaler, Michael Hubalek, Katja Schmitz, Zsuzsanna Bago‐Horvath, Andreas Petzer, Sonja Heibl, Ellen Heitzer, Marija Balic, Michael Gnant

    Published 2025-07-01

    The advancements in the detection and characterization of circulating tumor DNA (ctDNA) have revolutionized precision medicine and are likely to transform standard clinical practice. The non‐invasive nature of this approach allows for molecular profiling of the entire tumor entity, while also enabli...

    Full description

    Get full text
    Article
  11. 11

    Noradrenaline for progressive supranuclear palsy syndromes (NORAPS): a randomised, double-blind, placebo-controlled, crossover Phase IIb clinical trial evaluating the efficacy and... by Robert Durcan, Christopher Kobylecki, Lee Shepstone, James B Rowe, Alistair Church, Duncan Street, Vicky Marshall, Charlotte Russell, Luca Passamonti, Juliet High, Christopher T Rodgers, Boyd C P Ghosh, Kelly Grant, Natalia Igosheva, Hugo Paula, Colin McAlister, Simon P Jones, Rong Ye, Chrystalina Antoniades

    Published 2025-07-01

    Introduction Progressive supranuclear palsy (PSP) is a devastating neurodegenerative disease characterised by cognitive, behavioural and motor problems. Motor symptoms are highly disabling, while cognitive and behavioural changes have a major impact on carer burden, quality of life and prognosis. Ap...

    Full description

    Get full text
    Article
  12. 12

    Identification and engineering of potent bispecific antibodies that protect against herpes simplex virus recurrent disease by Chingwei V. Lee, Hector Viadiu, Apurva Kalamkar, David I. Bernstein, Andrew Pae, Xinchao Yu, Sylvia Wong, Fernando J. Bravo, Sheng Ding, Elbert Seto, Magdeleine Hung, Yu Yu, Weimei Xing, Giuseppe A. Papalia, Wei Kan, Brian Carr, Majlinda Thomas, Leah Tong, Priyanka Desai, Nadine Jarrousse, Alexandre Mercier, Meghan M. Holdorf, Simon P. Fletcher, Emma Abernathy

    Published 2025-08-01

    Summary: Herpes simplex virus (HSV) causes lifelong infections, including oral and genital herpes. There is no vaccine, and current antivirals are only partially effective at reducing symptoms and transmission. Therapeutic antibodies offer a potentially long-acting treatment option, although efforts...

    Full description

    Get full text
    Article
  13. 13

    Quality of vitamin K antagonist treatment during the last year of life by Chantal Visser, Eva K. Kempers, Jamilla Goedegebuur, Denise Abbel, Sarah J. Aldridge, Adrian Edwards, Michelle Edwards, Geert‐Jan Geersing, Anne Gulbech Ording, Sjef J. C. M. van deLeur, Kate J. Lifford, Isabelle Mahé, Simon P. Mooijaart, Melchior C. Nierman, Johanneke E. A. Portielje, Mette Søgaard, Sebastian Szmit, Nynke M. Wiersma, Simon I. R. Noble, Frederikus A. Klok, Qingui Chen, Suzanne C. Cannegieter, Eric C. T. Geijteman, Marieke J. H. A. Kruip, SERENITY Consortium

    Published 2025-05-01

    Abstract Limited data exist on the quality of anticoagulation in patients approaching the end of life. This study evaluated vitamin K antagonist (VKA) anticoagulation control during the last year of life, using nationwide data from Statistics Netherlands, linked to anticoagulation clinics' data...

    Full description

    Get full text
    Article
  14. 14
  15. 15

    An interactive program for calculating groundwater flow regimes near shallow surface water bodies / by Townley, Lloyd R.

    Published 1992 Other Authors:
    Book